We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Product Liability “FDA Defense” Prospects Hampered By Vioxx Shrapnel

This article was originally published in The Tan Sheet

29 Nov 2004

News

The Tan Sheet

Executive Summary

An "FDA defense" from product liability punitive damages will be a tough sell on Capitol Hill in the next session, in light of burgeoning concerns about FDA's handling of Vioxx and agency oversight of approvals and postmarketing